MACD: Histogram at -0.114 (below zero) and negatively contracting — still bearish; contraction hints selling pressure may be slowing, but not a confirmed reversal.
RSI(6): ~20.0 (oversold/very weak). This can produce sharp bounces, but oversold alone is not a buy trigger without confirmation.
Key levels: Pivot 1.291 (far above), Resistance R1 1.836 / R2 2.173. Supports S1 0.745 and S2 0.409. Current pre-market (~0.702) is below S1, which is technically negative and suggests S2 becomes the next downside reference if weakness persists.
Positive Catalysts
can set up a short-lived technical bounce.
Neutral/Negative Catalysts
Strong bearish structure (stacked bearish moving averages) with price trading below nearby support (S1 0.745).
No recent news catalysts to change sentiment or drive a reversal.
Trading trends: Hedge funds neutral and insiders neutral (no supportive accumulation signal).
Earnings risk on 2026-02-13: if results disappoint, downside can accelerate given weak technicals.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 525,915 (0.00% YoY) — essentially flat, no growth momentum.
Net income: -8,351,326 (improved 42.82% YoY) — still deeply negative despite improvement.
EPS: -5.55 (down -90.30% YoY) — major deterioration in per-share results.
Gross margin: -9.71 — negative margin indicates poor unit economics/operations in the period.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating / price target change data provided; Wall Street positioning cannot be confirmed from the dataset.
Practical read-through: lack of visible coverage/updates plus weak financials and bearish technicals tilts the pro/con balance negative.
Influential/political trading check: No recent congress trading data available (no signal from politician activity in the last 90 days).
Wall Street analysts forecast AVX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVX is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast AVX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVX is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
